Ampio Pharm Stock Price Prediction
| AMPE Stock | USD 0.01 0.00 0.00% |
Momentum 57
Buy Extended
Oversold | Overbought |
Using Ampio Pharm hype-based prediction, you can estimate the value of Ampio Pharm from the perspective of Ampio Pharm response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ampio Pharm to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Ampio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ampio Pharm after-hype prediction price | USD 0.005243 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ampio |
Ampio Pharm After-Hype Price Prediction Density Analysis
As far as predicting the price of Ampio Pharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ampio Pharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Ampio Pharm, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ampio Pharm Estimiated After-Hype Price Volatility
In the context of predicting Ampio Pharm's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ampio Pharm's historical news coverage. Ampio Pharm's after-hype downside and upside margins for the prediction period are 0.00 and 50.27, respectively. We have considered Ampio Pharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ampio Pharm is out of control at this time. Analysis and calculation of next after-hype price of Ampio Pharm is based on 3 months time horizon.
Ampio Pharm Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ampio Pharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ampio Pharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ampio Pharm, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
118.77 | 339.85 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 0.83 |
|
Ampio Pharm Hype Timeline
Ampio Pharm is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ampio is projected to increase in value after the next headline, with the price projected to jump to 0.005243 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 0.83%, whereas the daily expected return is presently at 118.77%. The volatility of related hype on Ampio Pharm is about 0.0%, with the expected price after the next announcement by competition of 0.01. Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Ampio Pharm Basic Forecasting Models to cross-verify your projections.Ampio Pharm Related Hype Analysis
Having access to credible news sources related to Ampio Pharm's direct competition is more important than ever and may enhance your ability to predict Ampio Pharm's future price movements. Getting to know how Ampio Pharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ampio Pharm may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CALA | Calithera Biosciences | 0.00 | 0 per month | 23.19 | 0.20 | 150.00 | (66.67) | 583.33 | |
| ONPH | Oncology Pharma | 0.00 | 0 per month | 29.11 | 0.20 | 200.00 | (66.67) | 1,995 | |
| IVBT | Innovation1 Biotech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PANC | Panacos Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TNGNQ | Tengion | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STAB | Statera Biopharma | 0.00 | 0 per month | 19.28 | 0.20 | 100.00 | (50.00) | 266.67 | |
| BXRXQ | Baudax Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARNI | Arno Therapeutics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 | |
| KLDO | Kaleido Biosciences | 0.00 | 0 per month | 0.00 | 0.17 | 0.00 | 0.00 | 4,998 |
Ampio Pharm Additional Predictive Modules
Most predictive techniques to examine Ampio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ampio using various technical indicators. When you analyze Ampio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ampio Pharm Predictive Indicators
The successful prediction of Ampio Pharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ampio Pharm, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ampio Pharm based on analysis of Ampio Pharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ampio Pharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ampio Pharm's related companies.
Story Coverage note for Ampio Pharm
The number of cover stories for Ampio Pharm depends on current market conditions and Ampio Pharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ampio Pharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ampio Pharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ampio Pharm Short Properties
Ampio Pharm's future price predictability will typically decrease when Ampio Pharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ampio Pharm often depends not only on the future outlook of the potential Ampio Pharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ampio Pharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 810.1 K | |
| Cash And Short Term Investments | 4.1 M |
Complementary Tools for Ampio Pink Sheet analysis
When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |